Business · 29/05/2026Updated: 10/17/2026 · 1 min read
FDA Renews Psychopharmacologic Drugs Advisory Committee for 2 Years
Summary
The FDA has renewed the Psychopharmacologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on June 4, 2028.